On May 31, 2012, Vertex Pharmaceuticals (VRTX) had a market capitalization of $12.7B, based on 211.34M shares at a price of $60.04.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
May 31 2012 | $60.04 | 4,080,000 | 211,344,000 | $12,689,093,760.00 |
May 30 2012 | $60.18 | 10,180,000 | 211,344,000 | $12,718,681,920.00 |
May 29 2012 | $57.80 | 20,860,000 | 211,344,000 | $12,215,683,200.00 |
May 25 2012 | $64.85 | 1,970,000 | 211,344,000 | $13,705,658,400.00 |
May 24 2012 | $64.09 | 2,540,000 | 211,344,000 | $13,545,036,960.00 |
May 23 2012 | $63.94 | 2,170,000 | 211,344,000 | $13,513,335,360.00 |
May 22 2012 | $63.09 | 2,510,000 | 211,344,000 | $13,333,692,960.00 |
May 21 2012 | $62.10 | 2,930,000 | 211,344,000 | $13,124,462,400.00 |
May 18 2012 | $61.34 | 3,440,000 | 211,344,000 | $12,963,840,960.00 |
May 17 2012 | $61.27 | 3,140,000 | 211,344,000 | $12,949,046,880.00 |
May 16 2012 | $62.61 | 2,840,000 | 211,344,000 | $13,232,247,840.00 |
May 15 2012 | $63.38 | 4,010,000 | 211,344,000 | $13,394,982,720.00 |
May 14 2012 | $64.70 | 7,670,000 | 211,344,000 | $13,673,956,800.00 |
May 11 2012 | $62.02 | 3,250,000 | 211,344,000 | $13,107,554,880.00 |
May 10 2012 | $60.19 | 5,310,000 | 211,344,000 | $12,720,795,360.00 |
May 09 2012 | $60.35 | 10,430,000 | 211,344,000 | $12,754,610,400.00 |
May 08 2012 | $64.16 | 16,130,000 | 211,344,000 | $13,559,831,040.00 |
May 07 2012 | $58.12 | 40,220,000 | 211,344,000 | $12,283,313,280.00 |
May 04 2012 | $37.41 | 1,890,000 | 211,344,000 | $7,906,379,040.00 |
May 03 2012 | $38.11 | 1,610,000 | 211,344,000 | $8,054,319,840.00 |
May 02 2012 | $38.36 | 1,940,000 | 211,344,000 | $8,107,155,840.00 |
May 01 2012 | $38.45 | 2,040,000 | 211,344,000 | $8,126,176,800.00 |
